Attualità

IB Biotech, the biotechnology and genetics company which is part of the Instituto Bernabeu group, has launched a renewed version of its website, www.ibbiotech.com. The webpage is an alternative means of bringing investigation on genetics closer to society as a whole through intuitive browsing which is accessible from any device. 

The new Instituto Bernabeu Group newsletter is now available, dedicated to our last achievements on research & development. 

The Ministry of Economy and Competitiveness has awarded Instituto Bernabeu the title of Innovative Company which is given to companies with a proven track record in innovation and in their ability to be innovative in R&D work.

The age at which patients undergo fertility treatment has increased considerably over the last few years. Prognosis is poorer in older patients when it comes to IVF treatment. This is due, in part, to the high percentage of embryos with chromosomal abnormalities.